Posted in | News | Nanobusiness

Nanogen Announces Change in Board of Directors

Nanogen has announced that Dr. William G. Gerber, a non-independent member of the company's board of directors, resigned from the board, effective as of May 1, 2007. His resignation restores compliance with NASDAQ Marketplace Rule 4350(c)(1), which requires a majority of members of the board of directors to be comprised of independent directors. The non-compliance resulted from the appointment of Dr. Heiner Dreismann, a non-independent director, to the company's board on October 31, 2006.

The board of directors now is comprised of five directors, three of whom are independent within the meaning of the applicable NASDAQ listing standards.

On May 10, 2007, Nanogen, Inc. received a Nasdaq Staff Deficiency Letter indicating that the Company did not comply with the requirement for continued listing set forth in NASDAQ Marketplace Rule 4350(c)(1). As of the date of this press release, the company is again in full compliance with Nasdaq Marketplace Rule 4350(c)(1).

http://www.nanogen.com

Posetd 15th May 2007

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2019, March 19). Nanogen Announces Change in Board of Directors. AZoNano. Retrieved on June 22, 2024 from https://www.azonano.com/news.aspx?newsID=4101.

  • MLA

    Nanogen. "Nanogen Announces Change in Board of Directors". AZoNano. 22 June 2024. <https://www.azonano.com/news.aspx?newsID=4101>.

  • Chicago

    Nanogen. "Nanogen Announces Change in Board of Directors". AZoNano. https://www.azonano.com/news.aspx?newsID=4101. (accessed June 22, 2024).

  • Harvard

    Nanogen. 2019. Nanogen Announces Change in Board of Directors. AZoNano, viewed 22 June 2024, https://www.azonano.com/news.aspx?newsID=4101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.